1 – Cisco Systems (CSCO) is the dominant player in internet switches and routers, but about 40% of overall sales comes from steady revenue streams in its software and services businesses. Cisco’s $34.6 billion in cash and short-term investments gives it plenty of latitude to raise dividends or make acquisitions. The stock yields 2.5%. In May, the company reported that fiscal third-quarter earnings were 13% above the same period in 2018. And company executives said during a quarterly earnings call that Cisco has slashed its manufacturing in China, reducing potential damage from a trade war between the U.S. and China.
2 – Danaher (DHR) is a health care equipment maker on a hot streak. Shares are up nearly 30% so far in 2019 and trade at 26 times projected year-ahead earnings. And yet, says Mike Bailey, director of research at FBB Capital Partners, the market doesn’t fully appreciate the growth potential stemming from Danaher’s recent mega-acquisition of General Electric’s biopharmaceutical business. The unit is a leading provider of instruments, equipment and software supporting the discovery, development and manufacture of complex, biologic drugs.
3 – Walmart (WMT)… Not many retailers can give Amazon.com a run for its money, but Walmart is giving it a go. Analysts at CFRA bumped up their rating on the stock from “buy” to “strong buy” after the retailer reported boffo first-quarter earnings, including a 37% jump in U.S. e-commerce sales. The retailer also announced plans to introduce free next-day shipping on orders over $35. “We think the offer will help it take e-commerce market share from Amazon,” say CFRA analysts. They see the stock trading at $115 within the next 12 months.
4 – Zoetis (ZTS)… Ahead of the 2020 election, talk of potential Medicare and Medicaid changes, among other things, has spooked many health care investors. But Zoetis, the world’s biggest animal health company, is immune to election-year rhetoric. Every major division of its business, which makes vaccines, medicine and health products for a diverse lineup of livestock and pets, expanded in 2018. Managers at Eaton Vance Worldwide Health Sciences fund like the firm’s predictable revenue and its growing overseas footprint.
-Found This Helpful? Please Upvote & Follow @Valuemation For More..đź’™